These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


639 related items for PubMed ID: 3895668

  • 41. Adult kidney retransplantation: evolution of treatment and results over 25 years at the University of Minnesota.
    Fasola CG, Fryd DS, Fischel RJ, Ascher NL, Payne WD, Najarian JS.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2165-7. PubMed ID: 2652697
    [No Abstract] [Full Text] [Related]

  • 42. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 43. [Kaposi's sarcoma in kidney transplant treated with cyclosporin and azathioprine].
    Cózar JM, Martínez Piñeiro L, Avellana JA, de la Peña J, Hidalgo L, Sanz A, Burgos F, Martínez Piñeiro JA.
    Arch Esp Urol; 1990 Mar; 43(2):155-8. PubMed ID: 2363579
    [Abstract] [Full Text] [Related]

  • 44. Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution.
    Gruber SA, Chavers B, Payne WD, Fryd DS, Canafax DM, Simmons RL, Najarian JS, Matas A.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2139-40. PubMed ID: 2652690
    [No Abstract] [Full Text] [Related]

  • 45. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR, Goldman MH, Hastillo A, Szentpetery S, Wolfgang T, Thompson J, Mohanakumar T, Katz MR, Rider S, Hanrahan J.
    J Heart Transplant; 1985 Feb; 4(4):381-4. PubMed ID: 3916511
    [Abstract] [Full Text] [Related]

  • 46. Improved immunosuppression for heart transplantation.
    Bolman RM, Elick B, Olivari MT, Ring WS, Arentzen CE.
    J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The mechanism of hyperuricaemia in cyclosporine-treated renal transplant recipients.
    Cohen SL, Boner G, Rosenfeld JB, Shmueli D, Sperling O, Yusim A, Todd-Pokropek A, Shapira Z.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1829-30. PubMed ID: 3079042
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Cyclosporine and organ transplantation.
    Steinmuller DR.
    Cleve Clin Q; 1985 Feb; 52(2):263-70. PubMed ID: 3161666
    [No Abstract] [Full Text] [Related]

  • 51. Long-term nephrotoxicity of low doses of cyclosporine in heart transplant recipients.
    Ben Hmida M, Baumelou A, Desruesnnes M, Cabrol A, Pavie A, Grandjbakhch I, Cabrol C.
    Transplant Proc; 1995 Oct; 27(5):2725-7. PubMed ID: 7482891
    [No Abstract] [Full Text] [Related]

  • 52. Alternative immunosuppressive strategies in the management of recipients of living related renal transplants.
    Hodge E, Banowsky L, Novick A, Lewis R, Streem S, Steinmuller D, Holzmann J, McFarlin L, Graneto D, Medendorp SV.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1609-14. PubMed ID: 2652524
    [No Abstract] [Full Text] [Related]

  • 53. The influence of immunosuppression on the prevalence of aseptic bone necrosis after renal transplantation.
    Cotorruelo JG, De Francisco AL, Canga E, Amado JA, Riancho JA, De Bonis E, Zubimendi JA, Ruiz JC, Sanz de Castro S, Arias M.
    Transplant Proc; 1991 Aug; 23(4):2199-200. PubMed ID: 1871842
    [No Abstract] [Full Text] [Related]

  • 54. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
    Cardella CJ, Harding ME, deVeber GA, Honey J, Cook GT.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
    [No Abstract] [Full Text] [Related]

  • 55. Testicular function after renal transplantation: comparison of Cyclosporin A with azathioprine and prednisone combination regimes.
    Handelsman DJ, McDowell IF, Caterson ID, Tiller DJ, Hall BM, Turtle JR.
    Clin Nephrol; 1984 Sep; 22(3):144-8. PubMed ID: 6386252
    [Abstract] [Full Text] [Related]

  • 56. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P, Baron C, Fruchaud G, Hemery F, Desvaux D, Buisson C, Chopin D, Dahmane D, Remy P, Pastural M, Abbou C, Weil B, Lang P.
    Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
    [Abstract] [Full Text] [Related]

  • 57. Infectious diseases in 450 kidney transplant recipients treated with cyclosporine in a single center.
    Takahashi K, Yagisawa T, Teraoka S, Tanabe K, Ebihara K, Fuchinoue S, Honda H, Toma T, Agishi T, Ota K.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1563-6. PubMed ID: 2652508
    [No Abstract] [Full Text] [Related]

  • 58. Lymphokine responses in renal transplant recipients.
    MacSween JM, Cohen AD, Rajaraman K, Fox RA.
    Transplant Proc; 1982 Dec; 14(4):665-8. PubMed ID: 6762723
    [No Abstract] [Full Text] [Related]

  • 59. Management of cyclosporine toxicity by reduced dosage and azathioprine.
    Griffith BP, Hardesty RL, Lee A, Trento A, Thompson ME, Shapiro AP, Bahnson HT.
    J Heart Transplant; 1985 Dec; 4(4):410-3. PubMed ID: 3916516
    [Abstract] [Full Text] [Related]

  • 60. A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results.
    Kelly JJ, Walker RG, d'Apice AJ, Kincaid-Smith P.
    Transplant Proc; 1990 Oct; 22(5):2127-8. PubMed ID: 2219318
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 32.